Dear all
Please find below a statement from Ataxia UK regarding their position towards Omaveloxolone and FARA's campaign-
FARA has launched a campaign asking people affected with Friedreich's ataxia to sign their open letter to the US regulator, FDA, and Reata pharmaceuticals. The letter is to request Reata to submit a new drug application and for FDA to consider the approval of a new drug application for Omaveloxolone based on current evidence. You can find information about Omaveloxolone here-
ataxia.org.uk/research-news...
Currently the drug has not been approved for normal clinical use. Ataxia UK supports FARA's campaign. If you are interested in knowing more and to sign the letter, please go to this link:
curefa.org/advocacy?fbclid=...
Best wishes
Harriet